CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 84 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,017,277 | -42.9% | 635,798 | -48.3% | 0.04% | -47.3% |
| Q3 2022 | $1,783,000 | -20.8% | 1,229,545 | 0.0% | 0.07% | -12.9% |
| Q2 2022 | $2,250,000 | -14.0% | 1,229,545 | +25.5% | 0.08% | +6.2% |
| Q1 2022 | $2,617,000 | -38.3% | 980,085 | 0.0% | 0.08% | -32.2% |
| Q4 2021 | $4,244,000 | -22.7% | 980,085 | -9.1% | 0.12% | -23.9% |
| Q3 2021 | $5,488,000 | -19.6% | 1,078,103 | 0.0% | 0.16% | -1.9% |
| Q2 2021 | $6,824,000 | +12.3% | 1,078,103 | +37.2% | 0.16% | +16.2% |
| Q1 2021 | $6,075,000 | +205.6% | 785,899 | +159.0% | 0.14% | +195.7% |
| Q4 2020 | $1,988,000 | +49.4% | 303,465 | +51.6% | 0.05% | +39.4% |
| Q3 2020 | $1,331,000 | – | 200,224 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |